June 27, 2014 Non Regulatory InDex Pharmaceuticals announces results from COLLECT, a clinical trial of Kappaproct® in the treatment of moderate to severe Ulcerative Colitis Read more
June 27, 2014 Non Regulatory InDex Pharmaceuticals presenterar resultat från COLLECT, en klinisk studie av Kappaproct® för behandling av måttlig till svår ulcerös kolit Read more
April 1, 2014 Non Regulatory InDex Pharmaceuticals och Almirall ingår licensavtal för de europeiska rättigheterna till fas III läkemedelskandidaten Kappaproct Read more
April 1, 2014 Non Regulatory InDex Pharmaceuticals and Almirall enter into a license agreement for European rights of the phase III drug candidate Kappaproct Read more
February 25, 2014 Non Regulatory InDex Pharmaceuticals slutför finansieringsrunda om USD 20 m (EUR 15 m) och välkomnar NeoMed som ny aktieägare Read more
February 25, 2014 Non Regulatory InDex Pharmaceuticals closes $20 m financing round and welcomes NeoMed as new shareholder Read more